Abstract
Substance-P (SP) can function of mobilizing mesenchymal stem cells (MSCs) from the bone marrow to the circulation and exert anti-inflammatory effects by increasing anti-inflammatory M2-type macrophage and regulatory T cells in the circulation. The preclinical efficacy of SP was demonstrated in a variety of conditions including ischemia damages, but its safety was not assessed. In this study, we assessed the genotoxicity of SP by using in vitro bacterial reverse mutation assay, chromosomal aberration assay, and in vivo micronucleus test. The maximum test dose of SP was 250 μg/mL in a cell-based assay and 16.6 mg/kg for an in vivo test. Ames test revealed SP did not increase in the number of revertant colonies. An in vitro chromosomal aberration assay with Chinese hamster lung cells showed that SP was not clastogenic even at the maximum dose applied. In vivo micronucleus test also demonstrated that SP did not induce micronuclei formation in the bone marrow cells of male ICR mice. Taken together, our results suggest that SP is not mutagenic to bacterial cells. Moreover, SP does not cause chromosomal damage in mammalian cells either in vitro or in vivo.
Similar content being viewed by others
References
Quartara, L. & Maggi, C. A. The tachykinin NK1 receptor: Part l. Ligands and mechanisms of cellular activation. Neuropeptides 31:537–563 (1997).
Bost, K. L., Breeding, S. A. L. & Pascual, D. W. Modulation of the mRNAs encoding Substance P and its receptor in rat macrophage by LPS. Reg Immunol 4:105–112 (1992).
Ho, W. Z., Lai, J. P., Zhu, X. H., Uvaydova, M. & Douglas, S. D. Human monocytes and macrophages express Substance P and neurokinin-1 receptor. J Immunol 159:5654–5660 (1997).
Hiramoto, M. et al. Stimulatory effects of substance p on CD34 positive cell proliferation and differentiation in vitro are mediated by the modulation of stromal cell function. Int J Mol Med 1:347–354 (1998).
Libien, T. W. B cell lymphopoiesis in mouse and man. Curr Opin Immnonol 10:188–195 (1998).
Morrison, S. J., Shah, N. M. & Anderson, D. J. Regulatory mechanisms in stem cell biology. Cell 88:287–298 (1997).
Muller-Sieburg, C. E. & Deryugina, E. The stromal cells’ guide to the stem cell universe. Stem Cells 13: 477–486 (1995).
Rameshwar, P. & Gascon, P. Substance p (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: potential autoregulatory role for these cytokines in SP receptor expression and induction. Blood 6:482–490 (1995).
Rameshwar, P., Poddar, A. & Gascon, P. Hematopoietic regulation mediated by interactions among the neurokinins and cytokines. Leuk Lymph 28:1–10 (1997).
Raffaghello, L., Chiozzi, P., Falzoni, S., Di Virgilio, F. & Pistoia, V. The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. Cancer Res 66:907–914 (2006).
DeFea, K. A. et al. The proliferative and anti-apoptotic effects of Substance P are facilitated by formation of a b-arrestin-dependent scaffolding complex. Proc Natl Acad Sci 97:11086–11091 (2000).
Ziche, M., Morbidelli, L., Pacini, M., Dolara, P. & Maggi, C. A. NK1-receptors mediate the proliferative response of human fibroblasts to tachykinins. Br J Pharmacol 100:11–14 (1990).
Payan, D. G. Receptor-mediated mitogenic effects of Substance P on cultured smooth muscle cells. Biochem Biophys Res Commun 130:104–109 (1985).
Yang, C. M. et al. Substance P-induced activation of p42/44 mitogen-activated protein kinase associated with cell proliferation in human tracheal smooth muscle cells. Cell Signal 14:913–923 (2002).
Nakamura, M. et al. Promotion of corneal epithelial wound healing in diabetic rats by the combination of a substance P-derived peptide (FGLM-NH2) and insulin-like growth factor-1. Diabetologia 46:839–842 (2003).
Hong, H. S. et al. A new role of Substance P as an injury-inducible messenger for mobilization of CD29 (+) stromal-like cells. Nat Med 15:425–435 (2009).
An, Y. S. et al. Substance P stimulates the recovery of bone marrow after the irradiation. J Cell Physiol 226: 1204–1213 (2011).
Kang, M. H., Kim, D. Y., Yi, J. Y. & Son, Y. Substance-P accelerates intestinal tissue regeneration after gamma irradiation-induced damage. Wound Repair Regen 17: 216–223 (2009).
Delgado, A. V., McManus, A. T. & Chambers, J. P. Exogenous administration of Substance P enhances wound healing in a novel skin-injury model. Exp Biol Med (Maywood) 230:271–280 (2005).
Jiang, M. H. et al. Substance P induces M2-type macrophages after spinal cord injury. NeuroReport 23:786–792 (2012).
Jiang, M. H. et al. Substance P reduces apoptotic cell death possibly by modulating the immune response at the early stage after spinal cord injury. NeuroReport 24:846–851 (2013).
Hong, H. S. & Son, Y. Substance P ameliorates collagen II-induced arthritis in mice via suppression of the inflammatory response, Biochem Biophys Res Commun 453:179–184 (2014).
Chung, Y. S. et al. Genotoxicity study of water extract of Anemarrhena asphodeloid and Phellodendron amurense in bacterial and mammalian cell systems. Toxicol Res 20:43–47 (2004).
Maron, D. M. & Ames, B. N. Revised methods for the Salmonella mutagenicity test. Mutat Res 113:173–215 (1983).
Hong, M. Y., Kim, J. Y., Lee, Y. M. & Lee, M. Assessment of sensitivity of photo-chromosomal assay in the prediction of photo-carcinogenicity. Toxicol Res 21:99–105 (2005).
Dean, B. J. & Danford, N. Assays for the detection of chemically-induced chromosome damage in cultured mammalian cells. In Mutagenicity testing-a practical approach (eds Venitt, S. & Parry, J. M.) 187–232 (IRL Press Limited, Oxford, 1984).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hong, H.S., Yim, SV. & Son, Y. Genotoxicity studies of substance-P by using short-term assay. Mol. Cell. Toxicol. 12, 447–452 (2016). https://doi.org/10.1007/s13273-016-0049-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13273-016-0049-3